Format

Send to

Choose Destination

Prospects for gene therapy in hearing loss.

Author information

1
Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. karena@post.tau.ac.il

Abstract

Deafness is the most common form of sensory impairment in humans. Depending on the age of onset, hearing impairment can affect oral language acquisition, cognitive development and psychosocial development. Here, we cover the latest advances in gene therapy for alleviating or preventing hearing loss. This review is not meant to be comprehensive, but to highlight some of the most recent developments in the field. Several recent reviews have described potential therapeutic approaches.

PMID:
14558724
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center